Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;59(4):1117-1119.
doi: 10.1002/ppul.26856. Epub 2024 Jan 15.

Home spirometry monitoring to identify loss of asthma control in adolescents

Affiliations

Home spirometry monitoring to identify loss of asthma control in adolescents

Allison J Burbank et al. Pediatr Pulmonol. 2024 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
The distribution of FEV1pp values by day category (A), by frequency of self-reported rescue albuterol use (B), and by self-reported asthma status (C). YZE, yellow zone event; OCS, oral corticosteroid. *Categories are not necessarily mutually exclusive. Some days do not fall into any category so are not included.
Figure 2.
Figure 2.
FEV1pp values from pre-YZ days are shown in the spineplot. The higher the bar in each bin, the higher the probability of a YZ event occurring in the next 3 days. The spineplot demonstrates that the highest FEV1pp values were associated with the greatest probability of a YZ event occurring within the next 3 days. YZE, yellow zone event.

References

    1. Huang C, Izmailova ES, Jackson N, Ellis R, Bhatia G, Ruddy M, Singh D. Remote FEV1 Monitoring in Asthma Patients: A Pilot Study. Clin Transl Sci 2021;14:529–535. - PMC - PubMed
    1. Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM. Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2016;11:1973–1981. - PMC - PubMed
    1. Edmondson C, Westrupp N, Short C, Seddon P, Olden C, Wallis C, Brodlie M, Baxter F, McCormick J, MacFarlane S, Brooker R, Connon M, Ghayyda S, Blaikie L, Thursfield R, Brown L, Price A, Fleischer E, Hughes D, Donnelly C, Rosenthal M, Wallenburg J, Brownlee K, Alton E, Bush A, Davies JC. Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB-CF study. Pediatr Pulmonol 2023;58:2871–2880. - PubMed
    1. Edmondson C, Westrupp N, Seddon P, Olden C, Wallis C, Dawson C, Brodlie M, Baxter F, McCormick J, MacFarlane S, Rice D, Macleod A, Brooker R, Connon M, Ghayyda S, Blaikie L, Thursfield R, Brown L, Price A, Fleischer E, Itterman J, Hughes D, Barrett P, Surette M, Donnelly C, Mateos-Corral D, Padley G, Wallenburg J, Brownlee K, Alton E, Bush A, Davies JC. The feasibility of home monitoring of young people with cystic fibrosis: Results from CLIMB-CF. J Cyst Fibros 2022;21:70–77. - PubMed
    1. Cvietusa PJ, Goodrich GK, Shoup JA, King DK, Bender BG. Effect of an Asthma Exacerbation on Medication Adherence. J Allergy Clin Immunol Pract 2023;11:248–254. - PMC - PubMed